Adlai Nortye Biopharma Co., Ltd.

This study tested whether adding a new oral drug called buparlisib to a standard chemotherapy (paclitaxel) could help patients with advanced head and neck cancer live longer. It involved nearly 500 adults whose cancer had returned or spread after trying other modern immunotherapi…